Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies. | Clin Transl Med | 2022 | 35908284 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer. | Front Pharmacol | 2022 | 35903347 | PubTator, text mining | PubMed |
| Role of B-Cell in the Pathogenesis of Systemic Sclerosis. | Front Immunol | 2022 | 35903091 | PubTator, text mining | PubMed |
| Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation. | J Clin Med | 2022 | 35887984 | PubTator, text mining | PubMed |
| New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 35886899 | PubTator, text mining | PubMed |
| Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma. | Biomedicines | 2022 | 35885067 | PubTator, text mining | PubMed |
| Site-Specific Considerations on Engineered T Cells for Malignant Gliomas. | Biomedicines | 2022 | 35885047 | PubTator, text mining | PubMed |
| Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung Cancer. | Biomedicines | 2022 | 35884843 | PubTator, text mining | PubMed |
| Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils. | Cancers (Basel) | 2022 | 35884427 | PubTator, text mining | PubMed |
| Current State of Cell Therapies for Breast Cancer. | Cancer J | 2022 | 35880940 | PubTator, text mining | PubMed |
| γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells. | Front Immunol | 2022 | 35880177 | PubTator, text mining | PubMed |
| RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation. | J Transl Med | 2022 | 35879796 | PubTator, text mining | PubMed |
| Natural killer cells in antitumour adoptive cell immunotherapy. | Nat Rev Cancer | 2022 | 35879429 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35874720 | PubTator, text mining | PubMed |
| SNP-to-gene linking strategies reveal contributions of enhancer-related and candidate master-regulator genes to autoimmune disease. | Cell Genom | 2022 | 35873673 | PubTator, text mining | PubMed |
| Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. | Front Genet | 2022 | 35873464 | PubTator, text mining | PubMed |
| An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. | Front Med (Lausanne) | 2022 | 35872794 | PubTator, text mining | PubMed |
| Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells. | Sci Immunol | 2022 | 35867801 | PubTator, text mining | PubMed |
| Single-cell RNA Sequencing Analysis Reveals New Immune Disorder Complexities in Hypersplenism. | Front Immunol | 2022 | 35865544 | PubTator, text mining | PubMed |
| Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review. | J Exp Clin Cancer Res | 2022 | 35864520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=65